AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
7min chapter
Novo Nordisk, Eli Lilly and the GLP-1 economy
Unhedged
Navigating the GLP-1 Drug Landscape
This chapter examines the competitive dynamics between pharmaceutical giants Eli Lilly and Novo Nordisk in the GLP-1 drug market, particularly focusing on financial implications, regulatory challenges, and emerging competition. It highlights the upcoming changes in the market due to patent expirations and the potential shift towards oral medications, shaping the strategies necessary for maintaining their market positions.
00:00
Transcript
Episode notes
Get the Snipd
podcast app
Unlock the knowledge in podcasts with the podcast player of the future.
AI-powered
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode
Save any
moment
Hear something you like? Tap your headphones to save it with AI-generated key takeaways
Share
& Export
Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more
AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Discover
highlights
Listen to the best highlights from the podcasts you love and dive into the full episode